Fintel reports that on November 14, 2024, JP Morgan initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a ...

JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

In a recent interview, J.P. Morgan CEO Jamie Dimon expressed growing concerns about what’s happening in the world today, ...

Investor preferences seem to have shifted from gold to equities amid confidence in the President-elect's economic policies.

As more wealthy empty nesters stick to the North Shore rather than move to the Loop, the banking giant says they're looking ...

Our writer explores a trio of things that can trip up investors who are new to the stock market. Each can shred wealth rather ...

Curious about how to sell luxury real estate? Learn strategies to attract high-end buyers and boost your property’s value in ...

Organizations that embrace neurodivergent leaders are discovering significant competitive advantages. Diverse teams ...

In October, 14 new ETFs were made available to the Canadian market with two new issuers to choose from.

JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon said companies will look harder at acquisitions in the wake of the ...

The Federal Reserve is likely to pause its interest-rate cuts after December to assess the economic impact of policies under ...

A potential $3 billion IPO would be among the year’s biggest listings globally, Reuters reported. Venture Global’s ...